flumazenil has been researched along with Fibromyalgia in 1 studies
Flumazenil: A potent benzodiazepine receptor antagonist. Since it reverses the sedative and other actions of benzodiazepines, it has been suggested as an antidote to benzodiazepine overdoses.
flumazenil : An organic heterotricyclic compound that is 5,6-dihydro-4H-imidazo[1,5-a][1,4]benzodiazepine which is substituted at positions 3, 5, 6, and 8 by ethoxycarbonyl, methyl, oxo, and fluoro groups, respectively. It is used as an antidote to benzodiazepine overdose.
Fibromyalgia: A common nonarticular rheumatic syndrome characterized by myalgia and multiple points of focal muscle tenderness to palpation (trigger points). Muscle pain is typically aggravated by inactivity or exposure to cold. This condition is often associated with general symptoms, such as sleep disturbances, fatigue, stiffness, HEADACHES, and occasionally DEPRESSION. There is significant overlap between fibromyalgia and the chronic fatigue syndrome (FATIGUE SYNDROME, CHRONIC). Fibromyalgia may arise as a primary or secondary disease process. It is most frequent in females aged 20 to 50 years. (From Adams et al., Principles of Neurology, 6th ed, p1494-95)
Excerpt | Relevance | Reference |
---|---|---|
"Regional gray matter alterations in chronic pain, as detected with voxel-based morphometry of anatomical magnetic resonance images, are commonly interpreted to reflect neurodegeneration, but this assumption has not been tested." | 1.46 | Histological Underpinnings of Grey Matter Changes in Fibromyalgia Investigated Using Multimodal Brain Imaging. ( Araujo, D; Ceko, M; Daigle-Martel, A; Feier, NA; Fitzcharles, MA; Funck, T; Narayanan, S; Pomares, FB; Roy, S; Schweinhardt, P; Stikov, N; Thiel, A, 2017) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Pomares, FB | 1 |
Funck, T | 1 |
Feier, NA | 1 |
Roy, S | 1 |
Daigle-Martel, A | 1 |
Ceko, M | 1 |
Narayanan, S | 1 |
Araujo, D | 1 |
Thiel, A | 1 |
Stikov, N | 1 |
Fitzcharles, MA | 1 |
Schweinhardt, P | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Investigation of the Effect of Initial Central Sensitization Severity on Treatment Response in Patients With Fibromyalgia[NCT05020600] | 40 participants (Anticipated) | Observational | 2021-08-19 | Recruiting | |||
Investigation of the Relationship Between Neuropathic Complaints and Central Sensitization in Patients With Fibromyalgia[NCT05701696] | 111 participants (Anticipated) | Observational | 2023-01-16 | Recruiting | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
1 other study available for flumazenil and Fibromyalgia
Article | Year |
---|---|
Histological Underpinnings of Grey Matter Changes in Fibromyalgia Investigated Using Multimodal Brain Imaging.
Topics: Aged; Body Water; Brain Chemistry; Chronic Pain; Female; Fibromyalgia; Flumazenil; Gray Matter; Huma | 2017 |
Histological Underpinnings of Grey Matter Changes in Fibromyalgia Investigated Using Multimodal Brain Imaging.
Topics: Aged; Body Water; Brain Chemistry; Chronic Pain; Female; Fibromyalgia; Flumazenil; Gray Matter; Huma | 2017 |
Histological Underpinnings of Grey Matter Changes in Fibromyalgia Investigated Using Multimodal Brain Imaging.
Topics: Aged; Body Water; Brain Chemistry; Chronic Pain; Female; Fibromyalgia; Flumazenil; Gray Matter; Huma | 2017 |
Histological Underpinnings of Grey Matter Changes in Fibromyalgia Investigated Using Multimodal Brain Imaging.
Topics: Aged; Body Water; Brain Chemistry; Chronic Pain; Female; Fibromyalgia; Flumazenil; Gray Matter; Huma | 2017 |